TrialThe oncologist2012

Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration.

Alfredo Berruti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.